glp 1 drugs compounding pharmacy Congress Introduces SAFE Act of 2025, Expanding FDA Oversight of Compounded GLP-1 Drugs and Telehealth Providers How Compounded GLP-1s Are Challenging

En animales, el sinttico aument la vida media en Drosophila un 11-16% , pero el estudio insignia en ratones SHR (Anisimov 2003) no cambi la vida media : movi biomarcadores (funcin estral, un 17% menos de aberraciones cromosmicas) y redujo tumores espontneos

Preliminary cardiovascular outcome data on tirzepatide in type 2 diabetes The above-mentioned preliminary cardiovascular safety data from the SURPASS-4 study demonstrated no excess cardiovascular risk associated with tirzepatide therapy (73)

It currently is not indicated for any indications outside of that particular use

The effect is from reduced melanin production and lower oxidative stress